Literature DB >> 19254588

Docosahexaenoic acid pretreatment confers neuroprotection in a rat model of perinatal cerebral hypoxia-ischemia.

Deborah R Berman1, Ellen Mozurkewich, Yiqing Liu, John Barks.   

Abstract

OBJECTIVE: We hypothesized that pretreatment with docosahexaenoic acid (DHA), a potentially neuroprotective polyunsaturated fatty acid, would improve function and reduce brain damage in a rat model of perinatal hypoxia-ischemia. STUDY
DESIGN: Seven-day-old rats were divided into 3 treatment groups that received intraperitoneal injections of DHA 1, 2.5, or 5 mg/kg as DHA-albumin complex and 3 controls that received 25% albumin, saline, or no injection. Subsequently, rats underwent right carotid ligation followed by 90 minutes of 8% oxygen. Rats underwent sensorimotor testing (vibrissae-stimulated forepaw placing) and morphometric assessment of right-sided tissue loss on postnatal day 14.
RESULTS: DHA pretreatment improved forepaw placing response to near-normal levels (9.5 +/- 0.9 treatment vs 7.1 +/- 2.2 controls; normal = 10; P < .0001). DHA attenuated hemisphere damage compared with controls (P = .0155), with particular benefit in the hippocampus with 1 mg/kg (38% protection vs albumin controls).
CONCLUSION: DHA pretreatment improves functional outcome and reduces volume loss after hypoxia-ischemia in neonatal rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19254588      PMCID: PMC2824338          DOI: 10.1016/j.ajog.2009.01.020

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  27 in total

1.  Fetal monitoring: is it worth it?

Authors:  E J Quilligan; R H Paul
Journal:  Obstet Gynecol       Date:  1975-01       Impact factor: 7.661

2.  Synergy between antenatal exposure to infection and intrapartum events in causation of perinatal brain injury at term.

Authors:  Donald M Peebles; John S Wyatt
Journal:  BJOG       Date:  2002-07       Impact factor: 6.531

Review 3.  The onset of brain injury and neurodegeneration triggers the synthesis of docosanoid neuroprotective signaling.

Authors:  Nicolas G Bazan
Journal:  Cell Mol Neurobiol       Date:  2006-08-01       Impact factor: 5.046

Review 4.  Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways.

Authors:  D Hwang
Journal:  FASEB J       Date:  2001-12       Impact factor: 5.191

5.  Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection.

Authors:  Ludmila Belayev; Victor L Marcheselli; Larissa Khoutorova; Elena B Rodriguez de Turco; Raul Busto; Myron D Ginsberg; Nicolas G Bazan
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

6.  Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide.

Authors:  Sabrina Wang; Jia-Ying Yan; Yu-Kang Lo; Paul M Carvey; Zaodung Ling
Journal:  Brain Res       Date:  2009-02-21       Impact factor: 3.252

7.  Docosahexaenoic acid prevents lipopolysaccharide-induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization.

Authors:  Véronique De Smedt-Peyrusse; Françoise Sargueil; Aurélie Moranis; Hedi Harizi; Sébastien Mongrand; Sophie Layé
Journal:  J Neurochem       Date:  2007-11-16       Impact factor: 5.372

Review 8.  Omega-3 fatty acids and neurological injury.

Authors:  Adina T Michael-Titus
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2007-11-26       Impact factor: 4.006

9.  Neonatal cytokines and coagulation factors in children with cerebral palsy.

Authors:  K B Nelson; J M Dambrosia; J K Grether; T M Phillips
Journal:  Ann Neurol       Date:  1998-10       Impact factor: 10.422

Review 10.  Docosahexaenoic acid: membrane properties of a unique fatty acid.

Authors:  William Stillwell; Stephen R Wassall
Journal:  Chem Phys Lipids       Date:  2003-11       Impact factor: 3.329

View more
  27 in total

1.  Docosahexaenoic acid confers neuroprotection in a rat model of perinatal hypoxia-ischemia potentiated by Escherichia coli lipopolysaccharide-induced systemic inflammation.

Authors:  Deborah R Berman; Yi Qing Liu; John Barks; Ellen Mozurkewich
Journal:  Am J Obstet Gynecol       Date:  2010-03-31       Impact factor: 8.661

2.  Hypoxic Ischemic Encephalopathy: Pathophysiology and Experimental Treatments.

Authors:  Kimberly A Allen; Debra H Brandon
Journal:  Newborn Infant Nurs Rev       Date:  2011-09-01

3.  Fatty Acid Binding Protein 5 Modulates Docosahexaenoic Acid-Induced Recovery in Rats Undergoing Spinal Cord Injury.

Authors:  Johnny D Figueroa; Miguel Serrano-Illan; Jenniffer Licero; Kathia Cordero; Jorge D Miranda; Marino De Leon
Journal:  J Neurotrauma       Date:  2016-03-29       Impact factor: 5.269

4.  Omega-3 polyunsaturated fatty acid supplementation confers long-term neuroprotection against neonatal hypoxic-ischemic brain injury through anti-inflammatory actions.

Authors:  Wenting Zhang; Xiaoming Hu; Wei Yang; Yanqin Gao; Jun Chen
Journal:  Stroke       Date:  2010-08-12       Impact factor: 7.914

5.  Docosahexaenoic acid pretreatment confers protection and functional improvements after acute spinal cord injury in adult rats.

Authors:  Johnny D Figueroa; Kathia Cordero; Keisha Baldeosingh; Aranza I Torrado; Robert L Walker; Jorge D Miranda; Marino De Leon
Journal:  J Neurotrauma       Date:  2011-11-07       Impact factor: 5.269

6.  Docosahexaenoic acid augments hypothermic neuroprotection in a neonatal rat asphyxia model.

Authors:  Deborah R Berman; Ellen Mozurkewich; Yiqing Liu; Yu Shangguan; John D Barks; Faye S Silverstein
Journal:  Neonatology       Date:  2013-06-26       Impact factor: 4.035

7.  Characterization of Gene Expression in the Rat Brainstem After Neonatal Hypoxic-Ischemic Injury and Antioxidant Treatment.

Authors:  M Revuelta; O Arteaga; A Alvarez; A Martinez-Ibargüen; E Hilario
Journal:  Mol Neurobiol       Date:  2016-01-25       Impact factor: 5.590

Review 8.  Aging is not a disease: distinguishing age-related macular degeneration from aging.

Authors:  Daniel Ardeljan; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2013-08-09       Impact factor: 21.198

Review 9.  The challenge of understanding cerebral white matter injury in the premature infant.

Authors:  C M Elitt; P A Rosenberg
Journal:  Neuroscience       Date:  2014-05-15       Impact factor: 3.590

10.  The problem of pseudoreplication in neuroscientific studies: is it affecting your analysis?

Authors:  Stanley E Lazic
Journal:  BMC Neurosci       Date:  2010-01-14       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.